NHS England and NICE have approved the use of Tirzepatide, which you may also know as Mounjaro or 'the weight loss drug', from primary care. You may well hear that Tirzepatide is A new drug combo of semaglutide (GLP 1 receptor agonist) with cagrilintide (amylin analogue) failed to do as well as tirzepatide (GLP 1 GIP receptor agonist). The future of these medicines is hitting different receptors. Tirzepatide Reviews, Clinical Trials, and Safety What is cagrisema and how does it work for weight loss? Cagri Peptide Units Per Week TikTok Three new #obesity drugshigh dose semaglutide, semaglutide plus cagrilintide, and oral orforglipronmay soon be approved in the US. JAMA Medical News Director Jennifer Abbasi and Lead Senior Staff Writer Rita Rubin examine how